X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11937) 11937
Book Chapter (53) 53
Publication (25) 25
Conference Proceeding (16) 16
Dissertation (5) 5
Magazine Article (5) 5
Book Review (1) 1
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tolerability (11208) 11208
humans (7768) 7768
efficacy (4996) 4996
female (4930) 4930
male (4930) 4930
adult (3649) 3649
middle aged (3616) 3616
safety (3417) 3417
pharmacology & pharmacy (3235) 3235
double-blind (2629) 2629
treatment outcome (2592) 2592
aged (2576) 2576
pharmacokinetics (1820) 1820
clinical neurology (1648) 1648
adolescent (1634) 1634
double-blind method (1529) 1529
psychiatry (1427) 1427
drug therapy (1203) 1203
young adult (1094) 1094
dose-response relationship, drug (1073) 1073
care and treatment (924) 924
medicine & public health (908) 908
medicine, general & internal (879) 879
therapy (875) 875
analysis (860) 860
clinical trials (855) 855
aged, 80 and over (842) 842
child (798) 798
internal medicine (785) 785
neurosciences (778) 778
drug therapy, combination (777) 777
animals (775) 775
children (748) 748
prospective studies (719) 719
management (713) 713
drug administration schedule (672) 672
randomized controlled trials as topic (665) 665
multicenter (662) 662
epilepsy (653) 653
research (650) 650
trial (648) 648
schizophrenia (611) 611
placebo (609) 609
pharmacodynamics (598) 598
time factors (593) 593
administration, oral (581) 581
retrospective studies (573) 573
dosage and administration (568) 568
pharmacology/toxicology (564) 564
immunology (541) 541
medicine, research & experimental (537) 537
pharmacotherapy (537) 537
follow-up studies (517) 517
pharmacology (513) 513
health aspects (510) 510
quality of life (505) 505
hypertension (503) 503
oncology (477) 477
patients (465) 465
urology & nephrology (454) 454
open-label (451) 451
risk factors (450) 450
metaanalysis (437) 437
anticonvulsants - therapeutic use (435) 435
pain (430) 430
drugs (428) 428
child, preschool (427) 427
quality-of-life (421) 421
neurology (416) 416
pediatrics (416) 416
infectious diseases (413) 413
prevalence (411) 411
studies (405) 405
toxicology (395) 395
antipsychotic agents - therapeutic use (393) 393
drug dosages (392) 392
cross-over studies (387) 387
cardiac & cardiovascular systems (384) 384
seizures (378) 378
medical research (375) 375
adults (372) 372
severity of illness index (372) 372
prevention (363) 363
antiepileptic drugs (362) 362
clinical trials as topic (357) 357
risk (354) 354
antipsychotic agents - adverse effects (350) 350
antidepressants (344) 344
depression (344) 344
hypertension - drug therapy (344) 344
migraine (343) 343
drug interactions (337) 337
combination (334) 334
monotherapy (330) 330
usage (326) 326
complications and side effects (324) 324
placebo-controlled trial (320) 320
schizophrenia - drug therapy (319) 319
endocrinology & metabolism (306) 306
medicine, experimental (302) 302
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11108) 11108
German (345) 345
Spanish (170) 170
Russian (141) 141
French (117) 117
Italian (69) 69
Japanese (28) 28
Polish (21) 21
Portuguese (21) 21
Turkish (20) 20
Czech (14) 14
Korean (7) 7
Hungarian (5) 5
Chinese (2) 2
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 07/2018, Volume 91, Issue 4, pp. e364 - e373
OBJECTIVETo evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for... 
CONTROLLED-TRIAL | DICLOFENAC POTASSIUM | TRIPTANS SEROTONIN | EFFICACY | HEADACHE | 5-HT1B/1D AGONISTS | TOLERABILITY | DOUBLE-BLIND | OPEN-LABEL | PREVENTION AMPP | CLINICAL NEUROLOGY | 101 | 321 | 222 | 302
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
The pharmacokinetics (PK), safety, and tolerability of two repeated dosing regimens of oral fosfomycin tromethamine were evaluated in 18 healthy adult... 
Antimicrobial safety | Tolerability | Safety | Pharmacokinetics | Fosfomycin
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3412 - 3419
Abstract Purpose We assessed the safety of the multikinase inhibitor regorafenib in patients with hepatocellular carcinoma (HCC) that had progressed following... 
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | MANAGEMENT | EFFICACY | ONCOLOGY | SUNITINIB | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article
Neurology, ISSN 1526-632X, 2015, Volume 84, Issue 16, pp. 1705 - 1713
OBJECTIVE:To provide evidence-based recommendations for treatment of adults with an unprovoked first seizure. METHODS:We defined relevant questions and... 
MORTALITY | TONIC-CLONIC SEIZURE | PRACTICE PARAMETER | TOLERABILITY | RISK | RECURRENCE | QUALITY STANDARDS SUBCOMMITTEE | NEW-ONSET EPILEPSY | IMMEDIATE | CLINICAL NEUROLOGY | PREDICTION
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 8, pp. 724 - 734
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 10/2013, Volume 170, Issue 3, pp. 679 - 692
Journal Article
Drug discovery today, ISSN 1359-6446, 2013, Volume 18, Issue 17-18, pp. 807 - 817
Journal Article